Do analysts prefer WKSP or ASBP?

Worksport presently has a consensus target price of $2.00, suggesting a potential upside of 392.61%. Given Worksport's stronger consensus rating and higher possible upside, equities research analysts clearly believe Worksport is more favorable than Aspire Biopharma. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Worksport 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Aspire Biopharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts prefer UCAR or ASBP?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score U Power 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Aspire Biopharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, UCAR or ASBP?

U Power has higher revenue and earnings than Aspire Biopharma. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio U Power $5.85M 0.85 -$9.78M N/A N/A Aspire Biopharma $10K 1,243.20 -$24.48M -$69.62 N/A

Is UCAR or ASBP more profitable?

U Power has a net margin of 0.00% compared to Aspire Biopharma's net margin of -11,362.21%. Company Net Margins Return on Equity Return on Assets U Power N/A N/A N/A Aspire Biopharma -11,362.21% N/A -177.59%

Do analysts prefer REE or ASBP?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score REE Automotive 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Aspire Biopharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is REE or ASBP more profitable?

REE Automotive has a net margin of 0.00% compared to Aspire Biopharma's net margin of -11,362.21%. Company Net Margins Return on Equity Return on Assets REE Automotive N/A N/A N/A Aspire Biopharma -11,362.21% N/A -177.59%

Do analysts prefer ASBP or FRSX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aspire Biopharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Foresight Autonomous Holdings Ltd. American Depositary Shares 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is ASBP or FRSX more profitable?

Foresight Autonomous Holdings Ltd. American Depositary Shares has a net margin of 0.00% compared to Aspire Biopharma's net margin of -11,362.21%. Company Net Margins Return on Equity Return on Assets Aspire Biopharma -11,362.21% N/A -177.59% Foresight Autonomous Holdings Ltd. American Depositary Shares N/A N/A N/A

Do analysts recommend CREVW or ASBP?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Carbon Revolution Public 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Aspire Biopharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher valuation and earnings, CREVW or ASBP?

Carbon Revolution Public has higher revenue and earnings than Aspire Biopharma. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Carbon Revolution Public $80.31M N/A N/A N/A N/A Aspire Biopharma $10K 1,243.20 -$24.48M -$69.62 N/A

Is CREVW or ASBP more profitable?

Carbon Revolution Public has a net margin of 0.00% compared to Aspire Biopharma's net margin of -11,362.21%. Company Net Margins Return on Equity Return on Assets Carbon Revolution Public N/A N/A N/A Aspire Biopharma -11,362.21% N/A -177.59%

Aspire Biopharma (ASBP) Competitors

$8.88 +0.10 (+1.14%)

Closing price 10/5/2026 04:00 PM Eastern

Extended Trading

$8.81 -0.07 (-0.79%)

As of 10/5/2026 07:30 PM Eastern

Compare

ASBP vs. WKSP, UCAR, REE, FRSX, and CREVW

Should you buy Aspire Biopharma stock or one of its competitors? Aspire Biopharma's main competitors and comparable companies include Worksport (WKSP), U Power (UCAR), REE Automotive (REE), Foresight Autonomous Holdings Ltd. American Depositary Shares (FRSX), and Carbon Revolution Public (CREVW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "automotive parts & equipment" industry.

How does Aspire Biopharma compare to Worksport?

Worksport (NASDAQ:WKSP) and Aspire Biopharma (NASDAQ:ASBP) are both small-cap consumer discretionary companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, media sentiment, valuation, risk and institutional ownership.

In the previous week, Aspire Biopharma had 1 more articles in the media than Worksport. MarketBeat recorded 1 mentions for Aspire Biopharma and 0 mentions for Worksport. Worksport's average media sentiment score of 0.83 beat Aspire Biopharma's score of 0.00 indicating that Worksport is being referred to more favorably in the media.

Company	Overall Sentiment
Worksport	Positive
Aspire Biopharma	Neutral

Worksport has higher revenue and earnings than Aspire Biopharma. Worksport is trading at a lower price-to-earnings ratio than Aspire Biopharma, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Worksport	$16.10M	0.39	-$19.35M	-$2.34	N/A
Aspire Biopharma	$10K	1,243.20	-$24.48M	-$69.62	N/A

Worksport presently has a consensus target price of $2.00, suggesting a potential upside of 392.61%. Given Worksport's stronger consensus rating and higher possible upside, equities research analysts clearly believe Worksport is more favorable than Aspire Biopharma.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Worksport	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Aspire Biopharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Worksport has a beta of 0.41, indicating that its stock price is 59% less volatile than the broader market. Comparatively, Aspire Biopharma has a beta of 0.17, indicating that its stock price is 83% less volatile than the broader market.

Worksport has a net margin of -114.49% compared to Aspire Biopharma's net margin of -11,362.21%. Aspire Biopharma's return on equity of 0.00% beat Worksport's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Worksport	-114.49%	-102.57%	-73.69%
Aspire Biopharma	-11,362.21%	N/A	-177.59%

16.1% of Worksport shares are held by institutional investors. Comparatively, 19.2% of Aspire Biopharma shares are held by institutional investors. 5.8% of Worksport shares are held by insiders. Comparatively, 5.8% of Aspire Biopharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Worksport beats Aspire Biopharma on 11 of the 16 factors compared between the two stocks.

How does Aspire Biopharma compare to U Power?

U Power (NASDAQ:UCAR) and Aspire Biopharma (NASDAQ:ASBP) are both small-cap consumer discretionary companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, media sentiment, profitability, institutional ownership, earnings, valuation and dividends.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
U Power	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Aspire Biopharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

13.2% of U Power shares are owned by institutional investors. Comparatively, 19.2% of Aspire Biopharma shares are owned by institutional investors. 5.8% of Aspire Biopharma shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

U Power has a beta of 7.81, suggesting that its stock price is 681% more volatile than the broader market. Comparatively, Aspire Biopharma has a beta of 0.17, suggesting that its stock price is 83% less volatile than the broader market.

U Power has higher revenue and earnings than Aspire Biopharma.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
U Power	$5.85M	0.85	-$9.78M	N/A	N/A
Aspire Biopharma	$10K	1,243.20	-$24.48M	-$69.62	N/A

U Power has a net margin of 0.00% compared to Aspire Biopharma's net margin of -11,362.21%.

Company	Net Margins	Return on Equity	Return on Assets
U Power	N/A	N/A	N/A
Aspire Biopharma	-11,362.21%	N/A	-177.59%

In the previous week, Aspire Biopharma had 1 more articles in the media than U Power. MarketBeat recorded 1 mentions for Aspire Biopharma and 0 mentions for U Power. U Power's average media sentiment score of 0.00 equaled Aspire Biopharma'saverage media sentiment score.

Company	Overall Sentiment
U Power	Neutral
Aspire Biopharma	Neutral

Summary

U Power beats Aspire Biopharma on 6 of the 10 factors compared between the two stocks.

How does Aspire Biopharma compare to REE Automotive?

REE Automotive (NASDAQ:REE) and Aspire Biopharma (NASDAQ:ASBP) are both small-cap consumer discretionary companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, media sentiment, profitability, institutional ownership, earnings, valuation and dividends.

12.7% of REE Automotive shares are owned by institutional investors. Comparatively, 19.2% of Aspire Biopharma shares are owned by institutional investors. 5.8% of Aspire Biopharma shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
REE Automotive	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Aspire Biopharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

REE Automotive has a net margin of 0.00% compared to Aspire Biopharma's net margin of -11,362.21%.

Company	Net Margins	Return on Equity	Return on Assets
REE Automotive	N/A	N/A	N/A
Aspire Biopharma	-11,362.21%	N/A	-177.59%

Aspire Biopharma has lower revenue, but higher earnings than REE Automotive. Aspire Biopharma is trading at a lower price-to-earnings ratio than REE Automotive, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
REE Automotive	$1.30M	1.87	-$55.81M	-$5.28	N/A
Aspire Biopharma	$10K	1,243.20	-$24.48M	-$69.62	N/A

REE Automotive has a beta of 2.4, suggesting that its stock price is 140% more volatile than the broader market. Comparatively, Aspire Biopharma has a beta of 0.17, suggesting that its stock price is 83% less volatile than the broader market.

In the previous week, Aspire Biopharma had 1 more articles in the media than REE Automotive. MarketBeat recorded 1 mentions for Aspire Biopharma and 0 mentions for REE Automotive. REE Automotive's average media sentiment score of 0.00 equaled Aspire Biopharma'saverage media sentiment score.

Company	Overall Sentiment
REE Automotive	Neutral
Aspire Biopharma	Neutral

Summary

REE Automotive beats Aspire Biopharma on 6 of the 11 factors compared between the two stocks.

How does Aspire Biopharma compare to Foresight Autonomous Holdings Ltd. American Depositary Shares?

Aspire Biopharma (NASDAQ:ASBP) and Foresight Autonomous Holdings Ltd. American Depositary Shares (NASDAQ:FRSX) are both small-cap consumer discretionary companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitability, earnings, valuation and media sentiment.

19.2% of Aspire Biopharma shares are owned by institutional investors. Comparatively, 23.5% of Foresight Autonomous Holdings Ltd. American Depositary Shares shares are owned by institutional investors. 5.8% of Aspire Biopharma shares are owned by insiders. Comparatively, 10.6% of Foresight Autonomous Holdings Ltd. American Depositary Shares shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Foresight Autonomous Holdings Ltd. American Depositary Shares had 3 more articles in the media than Aspire Biopharma. MarketBeat recorded 4 mentions for Foresight Autonomous Holdings Ltd. American Depositary Shares and 1 mentions for Aspire Biopharma. Foresight Autonomous Holdings Ltd. American Depositary Shares' average media sentiment score of 0.27 beat Aspire Biopharma's score of 0.00 indicating that Foresight Autonomous Holdings Ltd. American Depositary Shares is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aspire Biopharma	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Foresight Autonomous Holdings Ltd. American Depositary Shares	0 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Foresight Autonomous Holdings Ltd. American Depositary Shares has higher revenue and earnings than Aspire Biopharma. Aspire Biopharma is trading at a lower price-to-earnings ratio than Foresight Autonomous Holdings Ltd. American Depositary Shares, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aspire Biopharma	$10K	1,243.20	-$24.48M	-$69.62	N/A
Foresight Autonomous Holdings Ltd. American Depositary Shares	$445K	3.93	-$12.10M	-$16.66	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aspire Biopharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Foresight Autonomous Holdings Ltd. American Depositary Shares	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Foresight Autonomous Holdings Ltd. American Depositary Shares has a net margin of 0.00% compared to Aspire Biopharma's net margin of -11,362.21%.

Company	Net Margins	Return on Equity	Return on Assets
Aspire Biopharma	-11,362.21%	N/A	-177.59%
Foresight Autonomous Holdings Ltd. American Depositary Shares	N/A	N/A	N/A

Aspire Biopharma has a beta of 0.17, indicating that its stock price is 83% less volatile than the broader market. Comparatively, Foresight Autonomous Holdings Ltd. American Depositary Shares has a beta of 0.7, indicating that its stock price is 30% less volatile than the broader market.

Summary

Foresight Autonomous Holdings Ltd. American Depositary Shares beats Aspire Biopharma on 11 of the 12 factors compared between the two stocks.

How does Aspire Biopharma compare to Carbon Revolution Public?

Carbon Revolution Public (NASDAQ:CREVW) and Aspire Biopharma (NASDAQ:ASBP) are both consumer discretionary companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, risk, valuation, profitability, institutional ownership and dividends.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Carbon Revolution Public	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Aspire Biopharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Carbon Revolution Public has higher revenue and earnings than Aspire Biopharma.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Carbon Revolution Public	$80.31M	N/A	N/A	N/A	N/A
Aspire Biopharma	$10K	1,243.20	-$24.48M	-$69.62	N/A

Carbon Revolution Public has a net margin of 0.00% compared to Aspire Biopharma's net margin of -11,362.21%.

Company	Net Margins	Return on Equity	Return on Assets
Carbon Revolution Public	N/A	N/A	N/A
Aspire Biopharma	-11,362.21%	N/A	-177.59%

19.2% of Aspire Biopharma shares are owned by institutional investors. 5.8% of Aspire Biopharma shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Aspire Biopharma had 1 more articles in the media than Carbon Revolution Public. MarketBeat recorded 1 mentions for Aspire Biopharma and 0 mentions for Carbon Revolution Public. Carbon Revolution Public's average media sentiment score of 0.00 equaled Aspire Biopharma'saverage media sentiment score.

Company	Overall Sentiment
Carbon Revolution Public	Neutral
Aspire Biopharma	Neutral

Summary

Aspire Biopharma beats Carbon Revolution Public on 4 of the 7 factors compared between the two stocks.

Get Aspire Biopharma News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ASBP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ASBP vs. The Competition

Export

Metric	Aspire Biopharma	Automobile Components Industry	Consumer Discretionary Sector	NASDAQ Exchange
Market Cap	$12.31M	$4.73B	$12.30B	$13.26B
Dividend Yield	N/A	2.33%	73.14%	17.36%
P/E Ratio	-0.13	10.32	44.22	26.20
Price / Sales	1,243.20	40.49	92.21	95.18
Price / Cash	N/A	10.38	18.17	34.70
Price / Book	-0.16	1.60	3.96	6.40
Net Income	-$24.48M	$70.95M	$444.24M	$381.07M
7 Day Performance	8.56%	-1.12%	-0.55%	-0.28%
1 Month Performance	0.11%	-7.54%	-4.91%	-4.51%
1 Year Performance	-98.08%	-2.42%	-7.18%	1.63%

Aspire Biopharma Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ASBP Aspire Biopharma	0.4374 of 5 stars	$8.88 +1.1%	N/A	-98.1%	$12.31M	$10K	N/A	N/A
WKSP Worksport	2.779 of 5 stars	$0.44 -0.3%	$6.75 +1,428.9%	-87.8%	$6.75M	$18.30M	N/A	10	Positive News Gap Down
UCAR U Power	0.8817 of 5 stars	$4.44 +5.7%	N/A	-99.1%	$5.72M	$41.13M	N/A	86	Positive News Upcoming Earnings Gap Up
REE REE Automotive	N/A	$0.08 flat	N/A	N/A	$2.42M	$1.30M	N/A	270
FRSX Foresight Autonomous Holdings Ltd. American Depositary Shares	0.6093 of 5 stars	$1.15 +1.8%	N/A	-83.9%	$1.86M	$445K	N/A	70	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ASBP) was last updated on 10/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aspire Biopharma (ASBP) Competitors

ASBP vs. WKSP, UCAR, REE, FRSX, and CREVW

How does Aspire Biopharma compare to Worksport?

Summary

How does Aspire Biopharma compare to U Power?

Summary

How does Aspire Biopharma compare to REE Automotive?

Summary

How does Aspire Biopharma compare to Foresight Autonomous Holdings Ltd. American Depositary Shares?

Summary

How does Aspire Biopharma compare to Carbon Revolution Public?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ASBP vs. The Competition

Aspire Biopharma Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Aspire Biopharma (ASBP) Competitors

ASBP vs. WKSP, UCAR, REE, FRSX, and CREVW

How does Aspire Biopharma compare to Worksport?

Does the media refer more to WKSP or ASBP?

Which has preferable earnings and valuation, WKSP or ASBP?

Do analysts prefer WKSP or ASBP?

Which has more risk and volatility, WKSP or ASBP?

Is WKSP or ASBP more profitable?

Do institutionals & insiders hold more shares of WKSP or ASBP?

Summary

How does Aspire Biopharma compare to U Power?

Do analysts prefer UCAR or ASBP?

Do insiders and institutionals believe in UCAR or ASBP?

Which has more risk & volatility, UCAR or ASBP?

Which has preferable valuation & earnings, UCAR or ASBP?

Is UCAR or ASBP more profitable?

Does the media prefer UCAR or ASBP?

Summary

How does Aspire Biopharma compare to REE Automotive?

Do insiders and institutionals believe in REE or ASBP?

Do analysts prefer REE or ASBP?

Is REE or ASBP more profitable?

Which has preferable valuation & earnings, REE or ASBP?

Which has more risk & volatility, REE or ASBP?

Does the media prefer REE or ASBP?

Summary

How does Aspire Biopharma compare to Foresight Autonomous Holdings Ltd. American Depositary Shares?

Do institutionals and insiders have more ownership in ASBP or FRSX?

Does the media refer more to ASBP or FRSX?

Which has preferable earnings & valuation, ASBP or FRSX?

Do analysts prefer ASBP or FRSX?

Is ASBP or FRSX more profitable?

Which has more volatility and risk, ASBP or FRSX?

Summary

How does Aspire Biopharma compare to Carbon Revolution Public?

Do analysts recommend CREVW or ASBP?

Which has higher valuation and earnings, CREVW or ASBP?

Is CREVW or ASBP more profitable?

Do institutionals and insiders believe in CREVW or ASBP?

Does the media prefer CREVW or ASBP?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ASBP vs. The Competition

Aspire Biopharma Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools